Drug-Herb Interactions - Course 2

Drug-Herb Interactions and the Matrix

by Greg Sperber
Art. N°: C-GS006

Approved by: Standard Certificate, NCCAOM, IVAS

Language: English

Course Type: Recorded Webinar

Course Length: 3 h

Course Notes: Notes are provided with this course.

Access Period: Lifetime


Drug-Herb Interactions - Course 2

Course Overview

We can predict potential drug-herb interactions. This course takes the basic pharmacology principles discussed in the Basics of Pharmacology course, including the ADME scheme and the therapeutic index, and applies them to understanding and predicting drug-herb interactions. In addition, recent areas of research related to interactions, such as p-glycoprotein and other transporters, will be discussed. The emphasis is on both the theoretical prediction and real world application of strategies for preventing and dealing with interactions. This includes a discussion about creating a Drug-Herb Interaction Matrix for determining an individual patient's risk. The template for the matrix will be provided as part of the course.

Course Objectives

  • Understand how the basics of pharmacokinetics, including the ADME scheme, and pharmacodynamics can be used to predict drug-herb interactions
  • Identify the risks involved with combining drugs and herbs
  • Create a Drug-Herb Interaction Matrix for assessing individual patient risk and as a tool for communication

Course Outline

0 hrs - 15 minIntroduction

15 min - 1.75 hrsDiscuss risk factors for drug-herb interactions, including pharmaco-kinetic and -dynamic aspects

1.75 hrs - 2.75 hrsDemonstrate how to create a Drug-Herb Interaction Matrix to facilitate risk assessment and patient communication

2.75 hrs - 3 hrsSummary


Dr. Greg Sperber is an author and also holds a Masters and Doctor of Acupuncture and Oriental Medicine from Pacific College of Oriental Medicine. He is a professor at PCOM and speaks internationally on TCM business and drug-herb interactions.
Course Length 3h
Course Language English
Course Type Recorded Webinar
Nessuno commento per questo articolo.